Tochimoto A[au] - Search Results

Year	Number of Results
2001	1
2002	2
2003	1
2006	2
2007	3
2010	2
2011	3
2015	2
2016	1
2017	1
2018	1
2019	1
2020	1
2021	1
2023	2
2024	1

1

Antifibrotic effect of apremilast in systemic sclerosis dermal fibroblasts and bleomycin-induced mouse model.

Higuchi T, Takagi K, Tochimoto A, Ichimura Y, Hirose H, Sawada T, Shibata N, Harigai M, Kawaguchi Y. Higuchi T, et al. Among authors: tochimoto a. Sci Rep. 2023 Nov 8;13(1):19378. doi: 10.1038/s41598-023-46737-1. Sci Rep. 2023. PMID: 37938601 Free PMC article.

2

Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis.

Terao C, Kawaguchi T, Dieude P, Varga J, Kuwana M, Hudson M, Kawaguchi Y, Matucci-Cerinic M, Ohmura K, Riemekasten G, Kawasaki A, Airo P, Horita T, Oka A, Hachulla E, Yoshifuji H, Caramaschi P, Hunzelmann N, Baron M, Atsumi T, Hassoun P, Torii T, Takahashi M, Tabara Y, Shimizu M, Tochimoto A, Ayuzawa N, Yanagida H, Furukawa H, Tohma S, Hasegawa M, Fujimoto M, Ishikawa O, Yamamoto T, Goto D, Asano Y, Jinnin M, Endo H, Takahashi H, Takehara K, Sato S, Ihn H, Raychaudhuri S, Liao K, Gregersen P, Tsuchiya N, Riccieri V, Melchers I, Valentini G, Cauvet A, Martinez M, Mimori T, Matsuda F, Allanore Y. Terao C, et al. Among authors: tochimoto a. Ann Rheum Dis. 2017 Jun;76(6):1150-1158. doi: 10.1136/annrheumdis-2016-210645. Epub 2017 Mar 17. Ann Rheum Dis. 2017. PMID: 28314753 Free PMC article. Review.

3

Genetic Susceptibility to Interstitial Lung Disease Associated with Systemic Sclerosis.

Tochimoto A, Kawaguchi Y, Yamanaka H. Tochimoto A, et al. Clin Med Insights Circ Respir Pulm Med. 2016 Mar 13;9(Suppl 1):135-40. doi: 10.4137/CCRPM.S23312. eCollection 2015. Clin Med Insights Circ Respir Pulm Med. 2016. PMID: 26997879 Free PMC article. Review.

4

Activation of the activin A-ALK-Smad pathway in systemic sclerosis.

Takagi K, Kawaguchi Y, Kawamoto M, Ota Y, Tochimoto A, Gono T, Katsumata Y, Takagi M, Hara M, Yamanaka H. Takagi K, et al. Among authors: tochimoto a. J Autoimmun. 2011 May;36(3-4):181-8. doi: 10.1016/j.jaut.2010.09.004. Epub 2011 Mar 5. J Autoimmun. 2011. PMID: 21377836

5

Characteristics of Japanese patients with systemic sclerosis complicated with calcinosis.

Takagi K, Kawamoto M, Higuchi T, Tochimoto A, Hirose H, Harigai M, Kawaguchi Y. Takagi K, et al. Among authors: tochimoto a. Int J Rheum Dis. 2021 Jun;24(6):803-808. doi: 10.1111/1756-185X.14121. Epub 2021 Apr 28. Int J Rheum Dis. 2021. PMID: 33909342

6

Capillary abnormalities observed by nailfold video-capillaroscopy in Japanese patients with systemic sclerosis.

Ichimura Y, Kawaguchi Y, Takagi K, Tochimoto A, Higuchi T, Kataoka S, Katsumata Y, Yamanaka H. Ichimura Y, et al. Among authors: tochimoto a. Mod Rheumatol. 2018 Nov;28(6):1066-1068. doi: 10.1080/14397595.2018.1430547. Epub 2018 Feb 8. Mod Rheumatol. 2018. PMID: 29357721 No abstract available.

7

Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatment.

Higuchi T, Takagi K, Tochimoto A, Ichimura Y, Norose T, Katsumata Y, Masuda I, Yamanaka H, Morohoshi T, Kawaguchi Y. Higuchi T, et al. Among authors: tochimoto a. Arthritis Res Ther. 2019 Apr 18;21(1):103. doi: 10.1186/s13075-019-1881-3. Arthritis Res Ther. 2019. PMID: 30999934 Free PMC article.

8

Clinical manifestations of neurological involvement in primary Sjögren’s syndrome.

Gono T, Kawaguchi Y, Katsumata Y, Takagi K, Tochimoto A, Baba S, Okamoto Y, Ota Y, Yamanaka H. Gono T, et al. Among authors: tochimoto a. Clin Rheumatol. 2011 Apr;30(4):485-90. doi: 10.1007/s10067-010-1458-7. Clin Rheumatol. 2011. PMID: 20393864

9

Sildenafil attenuates the fibrotic phenotype of skin fibroblasts in patients with systemic sclerosis.

Higuchi T, Kawaguchi Y, Takagi K, Tochimoto A, Ota Y, Katsumata Y, Ichida H, Hanaoka M, Kawasumi H, Tochihara M, Yamanaka H. Higuchi T, et al. Among authors: tochimoto a. Clin Immunol. 2015 Dec;161(2):333-8. doi: 10.1016/j.clim.2015.09.010. Epub 2015 Sep 24. Clin Immunol. 2015. PMID: 26387628

10

Association of elevated serum carbohydrate antigen 19-9 levels with extensive interstitial lung disease in patients with systemic sclerosis: A cross-sectional study.

Hirose H, Higuchi T, Takagi K, Tochimoto A, Ichimura Y, Katsumata Y, Harigai M, Kawaguchi Y. Hirose H, et al. Among authors: tochimoto a. Int J Rheum Dis. 2024 Jan;27(1):e14978. doi: 10.1111/1756-185X.14978. Epub 2023 Nov 20. Int J Rheum Dis. 2024. PMID: 37983908

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

23 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year